Skip to main content
. 2019 Jul 30;14:5785–5797. doi: 10.2147/IJN.S213974

Scheme 1.

Scheme 1

Schematic illustration of the fabrication of the HA-MSNs and their application for pH-responsive drug release after specific binding with cancer cells, as well as targeted cancer therapy in vivo.